Bioactive Compounds
-
BA1851 PibrentasvirSummary: Pibrentasvir is a novel pan-genotypic hepatitis C virus inhibitor. -
C6240 (3,4-Dimethoxyphenyl)acetic acidSummary: A synthetic intermediate and structural building block for drug synthesis featuring a methoxy aromatic structure. -
A4790 TBHQSummary: An organic phenolic compound that activates the Nrf2 and ERK pathways -
BA1850 LagociclovirSummary: Lagociclovir (FLG) is a nucleoside analog. -
C6135 Isonicotinic acidSummary: A metabolite used for research on isoniazid metabolism and related enzyme activity. -
A3335 Curcumin1 CitationTarget: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|TyrosinasesSummary: Specific histone and non-histone acetyltransferase inhibitor -
BA1849 HBV-IN-37Summary: HBV-IN-37 is an inhibitor. -
C6107 p-AnisaldehydeSummary: A naturally occurring aromatic aldehyde compound, used in research on insect behavior and drug design. -
BA1848 IsothiafludineSummary: Isothiafludine is a non-nucleoside anticompound with oral activity. -
M1045 3-Indoleacetic acid1 CitationSummary: A growth regulator that can promote plant cell differentiation and organ formation.

